CRL Intelligence

Why FDA applications actually get refused

438 published Complete Response Letters, classified by rejection category, deficiency sub-theme and GxP domain. Explore the record yourself, then read the full analysis of what the agency keeps writing and what it means for your next filing.

Complete Response Letters
438Complete Response Letters
Years covered
2002-2026Years covered
Rejection categories
11Rejection categories
Cite facility or inspection
~50%Cite facility or inspection
Atlas Analytics

Updated monthly from the openFDA transparency dataset

Atlas Compliance · openFDA transparency dataset

How teams use it

Pre-submission

Calibrate the risk register

Compare your filing's exposure against the categories that actually drive refusals, not the ones teams assume do.

Site readiness

Pressure-test the facility gate

Filter to facility and inspection deficiencies to see how often a site, not the science, held an application at the door.

Benchmarking

Track the shift over time

Follow category composition year by year, from the mid-2010s baseline through the 2024 peak in published letters.

The dashboard shows the pattern. The article explains it.

A walk through the sentences the FDA reuses across these letters, the limits of the published record, and five checks to run against a filing this quarter.